147 related articles for article (PubMed ID: 33425909)
1. Human Tyrosyl-DNA Phosphodiesterase 1 Possesses Transphosphooligonucleotidation Activity With Primary Alcohols.
Dyrkheeva N; Anarbaev R; Lebedeva N; Kuprushkin M; Kuznetsova A; Kuznetsov N; Rechkunova N; Lavrik O
Front Cell Dev Biol; 2020; 8():604732. PubMed ID: 33425909
[TBL] [Abstract][Full Text] [Related]
2. Tyrosyl-DNA phosphodiesterase I catalytic mutants reveal an alternative nucleophile that can catalyze substrate cleavage.
Comeaux EQ; Cuya SM; Kojima K; Jafari N; Wanzeck KC; Mobley JA; Bjornsti MA; van Waardenburg RC
J Biol Chem; 2015 Mar; 290(10):6203-14. PubMed ID: 25609251
[TBL] [Abstract][Full Text] [Related]
3. Human Tdp1 cleaves a broad spectrum of substrates, including phosphoamide linkages.
Interthal H; Chen HJ; Champoux JJ
J Biol Chem; 2005 Oct; 280(43):36518-28. PubMed ID: 16141202
[TBL] [Abstract][Full Text] [Related]
4. Analysis of the active-site mechanism of tyrosyl-DNA phosphodiesterase I: a member of the phospholipase D superfamily.
Gajewski S; Comeaux EQ; Jafari N; Bharatham N; Bashford D; White SW; van Waardenburg RC
J Mol Biol; 2012 Jan; 415(4):741-58. PubMed ID: 22155078
[TBL] [Abstract][Full Text] [Related]
5. Tyrosyl-DNA phosphodiesterase (Tdp1) (3'-phosphotyrosyl DNA phosphodiesterase).
Raymond AC; Burgin AB
Methods Enzymol; 2006; 409():511-24. PubMed ID: 16793421
[TBL] [Abstract][Full Text] [Related]
6. Tyrosyl-DNA phosphodiesterase I resolves both naturally and chemically induced DNA adducts and its potential as a therapeutic target.
Comeaux EQ; van Waardenburg RC
Drug Metab Rev; 2014 Nov; 46(4):494-507. PubMed ID: 25327705
[TBL] [Abstract][Full Text] [Related]
7. Targeting Tyrosyl-DNA phosphodiesterase I to enhance toxicity of phosphodiester linked DNA-adducts.
Brettrager EJ; van Waardenburg RCAM
Cancer Drug Resist; 2019; 2(4):1153-1163. PubMed ID: 31875206
[TBL] [Abstract][Full Text] [Related]
8. Dysregulated human Tyrosyl-DNA phosphodiesterase I acts as cellular toxin.
Cuya SM; Comeaux EQ; Wanzeck K; Yoon KJ; van Waardenburg RC
Oncotarget; 2016 Dec; 7(52):86660-86674. PubMed ID: 27893431
[TBL] [Abstract][Full Text] [Related]
9. In vitro complementation of Tdp1 deficiency indicates a stabilized enzyme-DNA adduct from tyrosyl but not glycolate lesions as a consequence of the SCAN1 mutation.
Hawkins AJ; Subler MA; Akopiants K; Wiley JL; Taylor SM; Rice AC; Windle JJ; Valerie K; Povirk LF
DNA Repair (Amst); 2009 May; 8(5):654-63. PubMed ID: 19211312
[TBL] [Abstract][Full Text] [Related]
10. Tyrosyl-DNA phosphodiesterase 2 (TDP2) repairs topoisomerase 1 DNA-protein crosslinks and 3'-blocking lesions in the absence of tyrosyl-DNA phosphodiesterase 1 (TDP1).
Tsuda M; Kitamasu K; Kumagai C; Sugiyama K; Nakano T; Ide H
DNA Repair (Amst); 2020; 91-92():102849. PubMed ID: 32460231
[TBL] [Abstract][Full Text] [Related]
11. [Tyrosyl-DNA Phosphodiesterase 1 Is a New Player in Repair of Apurinic/Apyrimidinic Sites].
Rechkunova NI; Lebedeva NA; Lavrik OI
Bioorg Khim; 2015; 41(5):531-8. PubMed ID: 26762090
[TBL] [Abstract][Full Text] [Related]
12. Insights into substrate binding and catalytic mechanism of human tyrosyl-DNA phosphodiesterase (Tdp1) from vanadate and tungstate-inhibited structures.
Davies DR; Interthal H; Champoux JJ; Hol WG
J Mol Biol; 2002 Dec; 324(5):917-32. PubMed ID: 12470949
[TBL] [Abstract][Full Text] [Related]
13. Tyrosyl-DNA Phosphodiesterase I a critical survival factor for neuronal development and homeostasis.
van Waardenburg RC
J Neurol Neuromedicine; 2016; 1(5):25-29. PubMed ID: 27747316
[TBL] [Abstract][Full Text] [Related]
14. Pre-steady state kinetics of DNA binding and abasic site hydrolysis by tyrosyl-DNA phosphodiesterase 1.
Kuznetsov NA; Lebedeva NA; Kuznetsova AA; Rechkunova NI; Dyrkheeva NS; Kupryushkin MS; Stetsenko DA; Pyshnyi DV; Fedorova OS; Lavrik OI
J Biomol Struct Dyn; 2017 Aug; 35(11):2314-2327. PubMed ID: 27687298
[TBL] [Abstract][Full Text] [Related]
15. Small molecule microarray identifies inhibitors of tyrosyl-DNA phosphodiesterase 1 that simultaneously access the catalytic pocket and two substrate binding sites.
Zhao XZ; Kiselev E; Lountos GT; Wang W; Tropea JE; Needle D; Hilimire TA; Schneekloth JS; Waugh DS; Pommier Y; Burke TR
Chem Sci; 2021 Jan; 12(11):3876-3884. PubMed ID: 34163656
[TBL] [Abstract][Full Text] [Related]
16. Probing the evolutionary conserved residues Y204, F259, S400 and W590 that shape the catalytic groove of human TDP1 for 3'- and 5'-phosphodiester-DNA bond cleavage.
Kiselev E; Dexheimer TS; Marchand C; Huang SN; Pommier Y
DNA Repair (Amst); 2018; 66-67():64-71. PubMed ID: 29747024
[TBL] [Abstract][Full Text] [Related]
17. Analysis of human tyrosyl-DNA phosphodiesterase I catalytic residues.
Raymond AC; Rideout MC; Staker B; Hjerrild K; Burgin AB
J Mol Biol; 2004 May; 338(5):895-906. PubMed ID: 15111055
[TBL] [Abstract][Full Text] [Related]
18. Mutation of TDP1, encoding a topoisomerase I-dependent DNA damage repair enzyme, in spinocerebellar ataxia with axonal neuropathy.
Takashima H; Boerkoel CF; John J; Saifi GM; Salih MA; Armstrong D; Mao Y; Quiocho FA; Roa BB; Nakagawa M; Stockton DW; Lupski JR
Nat Genet; 2002 Oct; 32(2):267-72. PubMed ID: 12244316
[TBL] [Abstract][Full Text] [Related]
19. The tyrosyl-DNA phosphodiesterase Tdp1 is a member of the phospholipase D superfamily.
Interthal H; Pouliot JJ; Champoux JJ
Proc Natl Acad Sci U S A; 2001 Oct; 98(21):12009-14. PubMed ID: 11572945
[TBL] [Abstract][Full Text] [Related]
20. Identification of novel inhibitors for the tyrosyl-DNA-phosphodiesterase 1 (Tdp1) mutant SCAN1 using virtual screening.
Mamontova EM; Zakharenko AL; Zakharova OD; Dyrkheeva NS; Volcho KP; Reynisson J; Arabshahi HJ; Salakhutdinov NF; Lavrik OI
Bioorg Med Chem; 2020 Jan; 28(1):115234. PubMed ID: 31831297
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
